AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06288971 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tele-rehabilitation of EF and specific cognitive processes underlying academic skills
Description: - Tele-rehabilitation intervention on FE (RuntheRAN and MemoRAN). The training will be conducted at home, with periodic meetings with the clinician, for 3 months, for approximately 4/5 days a week for approximately 30/40 minutes per day. An adult (e.g. a family member) will support the child in the treatment and ensure that the exercises are carried out adequately at home. One of the following tele-rehabilitation software will be used: RuntheRAN (RidiNet, Coopertiva Sociale Anastasis), a software that aims to strengthen the prerequisites of reading by requiring the timed and progressively faster naming of colour matrices or black and white figures. MemoRAN (RidiNet, Cooperativa Sociale Anastasis), which involves rapid naming exercises of stimuli (figures and colors) presented in matrices, within tasks that require inhibition, cognitive flexibility and updating in working memory.
Study NCT06288971 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Game-based tools for the rehabilitation of EF and motor planning
Description: - MondoELLI intervention (Cooperativa Sociale Anastasis) integrated with neuropsychomotor activities. The game-based app involves activities in small groups to strengthen various components of EF (interference control, inhibition, working memory, flexibility). The activities are organized with increasing difficulty, according to the self-adaptive algorithm, and within a narrative context.
Study NCT05330858 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ESK-001
Description: Oral tablet or liquid
Study NCT05330858 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rabeprazole
Description: Oral Tablet
Study NCT05338892 — intervention group
Intervention type: OTHER
Intervention: Non-Interventional
Description: No study treatment will be administered on this study.
Study NCT05271955 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: e-GOLIAH
Description: Usual care plus electronic tablet with games application e-GOLIAH (Gaming Open Library for Intervention in Autism at Home)
Study NCT05271955 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Usual care which combines speech therapy, psychomotor, educational or psychological care with a developmental and / or behavioral orientation and a school life support during schooling.
Study NCT06002347 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: STAC Parent Module for Middle School
Description: The STAC Parent Module is a 30-minute pre-recorded online presentation that includes normative feedback, didactic information, a review of the student STAC strategies and corresponding strategies parents can use to support students who act as defenders, and information about perceptions vs. facts about bullying.
Study NCT05847348 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PET/CT or PET/MRI
Description: PET/CT or PET/MRI will be acquired no sooner than 50 minutes post injection and not later than 100 minutes post injection with 68Ga-PSMA-11
Study NCT04433052 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: personalised prevention program (PPP)
Description: Study subjects in the PPP arm will be invited to return to the study site six times over a three-year period (at V2/start of the study, V3/mo2, V4/mo6, V5/mo12, V6/mo18 and V7/mo36) to receive lifestyle coaching and exercise prescriptions led by a delegated member of the site staff and supervised by the investigator. Information on drug treatment will also be given by the investigator. These activities will be assisted by digital tools specifically designed for this study, the CoroPrevention Tool Suite.
Study NCT05086263 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pico G2 4k
Description: On this virtual reality headset, it will be loaded with an educational virtual reality mock MRI training titled Ready Teddy. This training explains the procedure to the viewer and addresses common questions that individuals often have regarding an MRI. Furthermore, using audio/visual cues, when the viewer moves their head too much in a MRI like setting they are reminded to stay still. Biofeedback training is aimed to mimic the experience of the MRI with real audio recordings of image acquisition, in order to adequately train the view to stay still in an MRI procedure.
Study NCT06458647 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Video Streaming with Virtual Reality
Description: In the study, patients in the intervention group will be watched videos of natural landscapes such as mountains, beaches and waterfalls with virtual reality goggles before the angiography procedure.
Study NCT05667025 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conservative rehabilitation
Description: Joint range of motion, strengthening, balance-coordination and stretching exercises included in the conservative physiotherapy program 5 days a week for a total of 6 weeks
Study NCT05667025 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cycling Functional Electrical Stimulation in addition to Conservative Rehabilitation
Description: In addition to conservative treatment, cycling FES to the affected lower extremity for 20 minutes, 3 days a week for 4 weeks. During the treatment, the patient will be seated on a chair and her feet will be fixed to the pedal with velcro tape, and the comfort during the treatment will be provided with calf supports.
Study NCT05279911 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: low-level laser therapy (LLLT)
Description: low-level laser therapy (LLLT) with dental implants has been suggested to improve bone quality during osseointegration. Low-level laser (Gallium Aluminum Arsenide Diode \[Ga-Al-As\]) (wavelength: 808 nm, average power density: 50 mW, circular spot diameter:0.71 cm, spot area: 0.4cm2) in continuous mode was applied in six points in contact with peri-implant soft tissue (1.23 minutes in each point of application; dose per point 11 J) before and immediately after suturing. The application points were divided into two points in the labial region where the implant would be placed (apical and cervical); two points in the lingual region (apical and cervical); and two points in the occlusal direction. After suturing the laser protocol was repeated in the same points following the same protocol, resulting in a total dose of 66 J for each application moment (before and after implant placement).
Study NCT05065255 — intervention group
Intervention type: DEVICE
Intervention: SpeediCath® catheters
Description: Patients using SC catheters will be followed up in order to understand the major criteria in the choice of the catheter by the patients.
Study NCT04976829 — intervention group
Intervention type: DEVICE
Intervention: Antibiotic stewardship and healthcare-associated infections surveillance assisted by computer
Description: Implementation - in our tertiary care university hospital - of a computerized-decision support system (CDSS) facilitating antibiotic stewardship and of an electronic surveillance software (ESS) facilitating infection prevention and control activities
Study NCT05480449 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Autologous Humanized CD19-Directed Chimeric Antigen Receptor T-Cells (huCART19)
Description: The investigational agent in this protocol is humanized CART19 cells (huCART19). Autologous T cells will be engineered to express an extracellular single chain antibody (scFv) with specificity for CD19. This will be expected to redirect specificity of the transduced T cells for cells that express CD19, a molecule that is restricted in expression on the surface of the malignant cells and on normal B cells.
Study NCT04825431 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAS-205, [14C]TAS-205
Description: single oral administration under fasted conditions on day 1
Study NCT05039658 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IBI110 plus sintilimab
Description: Sintilimab is a NMPA approved high-affinity, ligand-blocking, humanized anti-programmed death-1 (PD-1) IgG4 antibody that blocks the binding of Programmed death-ligand 1 (PD-L1) and programmed death-ligand 2 (PD-L2) to PD-1.
Study NCT05039658 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IBI110
Description: BI110 is a high-affinity, ligand-blocking, humanized anti- Lymphocyte Activation Gene-3 (LAG-3) IgG4 antibody that blocks the binding of LAG-3 to MHCII.
Study NCT04831099 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Testosterone gel
Description: The route of administration is transdermal.
Study NCT04831099 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The route of administration is transdermal
Study NCT05747417 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: prismatic glasses
Description: prism glasses ranging from 4-10 prism diopters
Study NCT06496399 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: psychoeducation
Description: -The elderly's preferences for art therapy (art activities such as wood painting, creating shapes with mud) will be taken into account.~2-Expression of emotions through motivational interviewing 3-Conscious Awareness therapy, staying in the moment here and now 4- Hobbies (growing flowers, gardening, handicraft knitting, puzzle solving, card games, chess game, etc., organizing trips, cinema, movie events and so on)
Study NCT05283876 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Excimer light
Description: Excimer light sessions
Study NCT05068050 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Horse-assisted therapy
Description: 12 horse-assisted therapy sessions (45 mins each) for 6 weeks.~Each session will comprise the next stages:~Groundwork, Approachment and preparation of the horse, Warm up exercises~Development of the main part (riding):~Introduction - beginning: Breathing control and body awareness, maintain sitting (riding position) while walking on the horse, perceiving the movement Exercises for the postural and balance control: Variations in the walking of the horse, realize different figures in the arena (circles, serpentines, change direction...), Stopping and Walking, Arms situation combined with the movement of the horse All exercises are determined in the track design protocol Exercises for the acquisition of motion skills: Finished the riding with relaxation activities. Final part: Dismount the horse, Unsaddled and unbridle, feedback and goodbye procedure.
Study NCT05068050 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Physical exercise
Description: 12 physical exercise sessions (45 mins each) for 6 weeks. Each session Each session Lessons will be held by physical activity professionals. The proposed exercises are focussed on improving the articular movements, aerobic resistance and the proprioception, always on the premises of No Pain.~Lessons will be divided in three parts :~1. Warmup - 2. Main part - 3. Return to calm~Lessons will be hold online
Study NCT05386979 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Opioid free anesthesia technology
Description: We have adopted a variety of methods to replace the use of opioids in the process of balanced anesthesia.
Study NCT05386979 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Opioid free anesthesia technology
Description: We have adopted a variety of methods to replace the use of opioids in the process of balanced anesthesia.
Study NCT05329662 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Autologous adipose-derived mesenchymal stem cell administration for female with sexual functional deficiency
Description: * Patients in the two groups will receive two autologous AD-MSC administrations: the group A on day 0 and day 90 ± 7; the group B on day 180 ± 14 and day 270 ± 14.~* Dose: 1.0 x 106 cells/kg patient bodyweight.~* Route: intravenous infusion~ADSCs were collected after the third passage. On the day of transplantation, the ADSCs were harvested, washed twice with NaCl 0.9%, counted and resuspended in NaCl 0.9% in a total volume of 20 ml. Each participant received a dose of 1x10\^6 cells/kg body weight infused through the intravenous route within 30 minutes before being discharged after 24 hours
Study NCT05329662 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Autologous adipose-derived mesenchymal stem cell administration for female with sexual functional deficiency
Description: * Patients in the two groups will receive two autologous AD-MSC administrations: the group A on day 0 and day 90 ± 7; the group B on day 180 ± 14 and day 270 ± 14.~* Dose: 1.0 x 106 cells/kg patient bodyweight.~* Route: intravenous infusion~ADSCs were collected after the third passage. On the day of transplantation, the ADSCs were harvested, washed twice with NaCl 0.9%, counted and resuspended in NaCl 0.9% in a total volume of 20 ml. Each participant received a dose of 1x10\^6 cells/kg body weight infused through the intravenous route within 30 minutes before being discharged after 24 hours
Study NCT06399744 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: sclerotherapy
Description: injection of sclerosing agent (tetracycline or polidocanol) into ovarian cyst after aspiration of its contents
Study NCT04557033 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mindfulness intervention
Description: My Moments® application (app) is a tool used to facilitate expressive art creation in a digital photography media
Study NCT06399575 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Apnea Following Isocapnic Hypoxia
Description: Decreasing end-tidal partial pressure of oxygen to 50 mmHg for five minutes, targeting 80-85% peripheral oxygen saturation. The end-tidal partial pressure of carbon dioxide will remain +1 mmHg above baseline levels. After five minutes of hypoxia, participants will complete an apnea.
Study NCT04871256 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Septorhinoplasty
Description: This intervention will be performed by the same surgeon, after signing of patient inform consent.
Study NCT05607745 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: FMT and placebo
Description: Similar healthy diet counseling is given to all participants in both FMT and placebo group. FMT to placebo is given in 2:1.
Study NCT05607745 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: FMT and placebo
Description: Similar healthy diet counseling is given to all participants in both FMT and placebo group. FMT to placebo is given in 2:1.
Study NCT05810714 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Best Practice
Description: Receive usual care
Study NCT05810714 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Fecal Immunochemical Test
Description: Receive FIT kit
Study NCT05810714 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fecal Immunochemical Test
Description: Receive FIT kit
Study NCT05810714 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Education
Description: Receive audio brochure
Study NCT05810714 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Education
Description: Receive video brochure
Study NCT05810714 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Scheduled Notification
Description: Receive scheduled reminder
Study NCT05810714 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Survey Administration
Description: Ancillary studies
Study NCT05810714 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey Administration
Description: Ancillary studies
Study NCT05291559 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Enterade
Description: Enterade is a glucose-free, amino acid-based medical food containing specific amino acids (aspartic acid, valine, serine, threonine and tyrosine) in addition to electrolytes and a non-sugar sweetener.
Study NCT05291559 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo is an identical product to Enterade except without added amino acids.
Study NCT04821323 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indomethacin
Description: Indomethacin capsules will be administered orally.
Study NCT04821323 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Lactulose-mannitol
Description: Lactulose-mannitol solution will be administered orally.
Study NCT04561739 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Paclitaxel coated balloon
Description: The Paclitaxel coated balloon is a paclitaxel-eluting rapid exchange balloon catheter for PTCA. Paclitaxel is the pharmacologically active substance for anti-neointima, whereas iopromide, a well-tolerated nonionic x-ray contrast agent, acts as a release-supporting additive.~The active drug coating is located on the surface of the balloon, which contains 3 μg Paclitaxel per 1 mm2. The spray coating of the mixture of paclitaxel and iopromide of the Swide is via ultrasound, with the crystal size\<2um.
Study NCT04561739 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Sirolimus eluting stents
Description: The device has a backbone of L605 cobalt chromium. The stent has a open cell, in-phase, peak-to-valley design. The strut thickness is 86 μm and has a stent profile less than 1.12mm. The polymer coating of the stent is a styrene-butadiene block copolymer. The antiproliferative drug concentration is at 9 ug/mm, which 80% of the drug is released by 30 days.
Study NCT05100160 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gabapentin
Description: Given by PO
Study NCT05100160 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Given by PO
Study NCT06006429 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Numerical dental impression by intraoral scanner
Description: Intervention consists in an 3D intra oral representation of the oral cavity
Study NCT06164366 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 0 degrees 3D printed upper complete dentures
Description: 3d printed dentures at a build angle of 0 degrees
Study NCT06164366 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 45 degrees 3D printed upper complete dentures
Description: 3d printed dentures at a build angle of 45 degrees
Study NCT06251089 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CPC mouthwash
Description: 0.07% CPC mouthwash
Study NCT06251089 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo of the CPC mouthwash
Study NCT05545124 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Donafenib + Tislelizumab
Description: Donafenib 100mg, BID+Tislelizumab 200mg, D1; q3w
Study NCT04812808 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bazedoxifene 20 mg
Description: Bazedoxifene will be administered during the duration of the study in the experimental arm together with chemotherapy.~Prophylactic rivaroxaban (Xarelto®) 10 mg per day orally will be added to avoid thromboembolic events.
Study NCT04794764 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: McGrath Mac
Description: in a randomized order we evaluate the first pass success rate of the tracheal tube into the trachea.
Study NCT04794764 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Macintosh Laryngoscope
Description: in a randomized order we evaluate the first pass success rate of the tracheal tube into the trachea.
Study NCT05106608 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Energy density photobiomodulation (7.5)
Description: A total of 22 points will be treated (extraoral and intraoral). 2 sessions per week, for 3 months (24 sessions in total). In addition, a mobile health application (LAXER) will be provided.
Study NCT05106608 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Energy density photobiomodulation (3)
Description: A total of 22 points will be treated (extraoral and intraoral). 2 sessions per week, for 3 months (24 sessions in total). In addition, a mobile health application (LAXER) will be provided.
Study NCT05106608 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Sham placebo
Description: In addition, a mobile health application (LAXER) will be provided.
Study NCT05644197 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Multidisciplinary program
Description: Multidisciplinary program:~* APA interventions: 12 weeks Each week at home, cardio-respiratory endurance sessions for muscle strengthening and balance work from the Autohome interface (Neuradom) and one week supervised by an APA teacher.~* Nutrition interventions: A group nutrition workshop at the Hôpital Privé de Provence.~* Psychological intervention:~  5 sessions of 1h30 in group, the first session will take place at the Private Hospital of Provence and the others by videoconference.~An individual session the week following the last group session.~-Visit with the urologist, 5 weeks after the prostatectomy.
Study NCT01289379 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: High Frequency Jet Ventilation
Study NCT01289379 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: HFJV
Study NCT06510855 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DurAVR™ THV System
Description: DurAVR™ THV System - Transcatheter Aortic Valve Implantation (TAVI) Procedure
Study NCT04919668 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Simulated grocery shopping exercise
Description: Participants will click a link and simulate an online grocery shopping experience by selecting items for 12 grocery categories.
Study NCT04919668 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Simulated grocery shopping exercise
Description: Participants will click a link and simulate an online grocery shopping experience by selecting items for 12 grocery categories.
Study NCT05932303 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986278
Description: Specified dose on specified days